| Name | Title | Contact Details |
|---|
InTouch Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Katalyst Surgical is the industry leader in ophthalmic surgical instruments. Our experienced team has over 40 years of design, manufacturing, and quality control of ophthalmic surgical products. It is our goal to provide superior service paired with high quality ophthalmic products at a cost saving to our customers. We stand by our company-wide policy that the customer is always right... By continually gathering customer feedback and working with our highly skilled professional team, Katalyst Surgical continues to deliver unmatched ophthalmic instruments while increasing our number of loyal customers. Katalyst Surgical is a premier research and development facility... Keeping up with cutting edge products and the changing industry has allowed us to serve our customers with 100% satisfaction Superior products within your budget... Your business is important to our team at Katalyst Surgical. Our goal is to offer superior products with premium customer service within your budget. Committed to our customers... We greatly appreciate your feedback on our ophthalmic surgical instruments and repair services.
Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient`s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
Chase Ergonomics Inc. is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.